查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2139936

發現生物學服務市場：全球市場預測，2026-2032年

Discovery Biology Service Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，發現生物學服務市場將成長至 248.5 億美元，複合年成長率為 14.58%。

主要市場統計數據
基準年 2025 95.8億美元
預計年份：2026年 107.8億美元
預測年份 2032 248.5億美元
複合年成長率 (%) 14.58%

探索生物學服務：概述

發現生物學服務利用生物鑑定、疾病模型、生物標記分析及相關實驗室能力，為早期研究提供支持，以應對標靶檢驗、作用機制、安全性和治療反應等方面的挑戰。隨著研究機構對專業知識、應對力、可重複數據以及從假設到候選化合物評估的快速轉化能力的需求不斷成長，發現生物學服務的角色也在擴大。這種需求受到科學複雜性、外包策略、監管要求以及整合跨多個生物系統實驗結果的需求等因素的影響。

科學的複雜性正在改變藥物發現生物學的運作方式。

藥物研發計畫正從依賴單一檢測的證據轉向整合的轉化工作流程，將分子層面的見解與細胞、組織和生物層面的結果連結起來。基因組學、蛋白質組學、高內涵成像、類器官系統、單細胞分析和功能篩檢等領域的進步，提高了對證據深度和數據品質的要求。因此，服務供應商和研究團隊需要將專業平台與穩健的實驗設計、標準化的方案、清晰的監管鏈以及透明的報告結合。可重複性、生物安全性、倫理管治以及與下游開發的兼容性正成為核心的選擇標準，而非次要考慮因素。

人工智慧可以增強實驗設計和生物學解釋。

人工智慧正透過影像分析、模式識別、虛擬篩檢、檢測最佳化、文獻整合、生物標記發現和實驗結果預測等方式影響發現生物學。其累積影響取決於基礎數據的品質、多樣性和可追溯性。註釋不完善或缺乏代表性的資料集會放大偏差，並導致難以重複的結果。因此，實用化需要人工審核、檢驗的工作流程、模型監控、安全的資料基礎設施以及對智慧財產權和病患資訊的明確管控。人工智慧的價值在於它能夠補充實驗室專業知識並優先考慮實驗，而不是取代經驗檢驗。

區域洞察：能力、法規與協作推動普及

北美擁有成熟的生物醫學研究網路、強大的轉化研究基礎設施以及廣泛的專業實驗室資源。同時，拉丁美洲正透過學術合作、生物製藥活動以及區域相關疾病研究來增強其研究能力。歐洲將先進的科學研究能力與健全的資料保護、動物福利和法律規範結合。中東正透過機構投資、臨床夥伴關係和多元化發展來建構研究生態系統。儘管基礎設施和人才方面有限制，非洲在感染疾病、基因體學和區域生物學領域仍蘊藏著巨大的發展機會。亞太地區擁有高度發展的藥物研發中心和快速發展的研究能力，合作、人才培養、品管系統和跨境資料管治仍是其重點領域。

團體洞察：經濟與安全聯盟影響研究網路

儘管東南亞國協正在學術、臨床和生物技術研究領域建立更緊密的夥伴關係。金磚國家在科學、人口和疾病生物學方面呈現出顯著的多樣性，其夥伴關係受各國自身能力和數據獲取考量的影響。歐盟強調協調研究、標準統一和健全的隱私管治，而七國集團則透過現有的機構和資助體系支持先進的生物醫學創新。海灣合作理事會成員國正在投資生命科學基礎設施、精準醫療和技術驅動型研究。北約成員國繼續在私有的科學和倫理框架內開展工作，同時日益認知到生物安全防範、安全研究實踐和韌性供應鏈的重要性。

國家洞察：不同能力創造互補機遇

澳洲擁有強大的生物醫學研究基礎，在感染疾病、免疫學和轉化科學領域具備豐富的專業知識。巴西和墨西哥人口高度多元化，為疾病相關研究提供了巨大機遇，並擁有不斷發展的研究和臨床生態系統的支持。加拿大、美國、英國、法國、德國、義大利和西班牙都受益於成熟的大學、專業實驗室和規範的生物醫學網路，但其資金籌措結構和合規要求各不相同。中國、印度、日本和韓國擁有不斷提升的技術能力、先進的測量設備和傑出的科學研究人才，但各自在核准、數據和夥伴關係保持著獨特的環境。俄羅斯在某些生物學領域擁有科研實力，但其合作條件、准入和國際營運限制需要仔細考慮。

探索生物學領導者的優先行動指南

產業領導者應基於生物學挑戰和決策點，而非單一技術，來制定服務規範。他們還應評估合作夥伴的檢測方法驗證、轉化相關性、資料完整性、生物安全性、監管準備以及跨平台整合結果的能力。採用分階段採購模式可確保關鍵項目的連續性，同時保持柔軟性。各組織也應建立人工智慧驅動分析的管治，包括檢驗資料集、稽核追蹤、人工核准和網路安全措施。建立區域夥伴關係關係、記錄材料和數據的來源以及投資於可互操作系統，有助於增強韌性，並確保從發現洞察到開發決策的平穩過渡。

調查方法：基於證據的執行綜合分析

本執行摘要分析了「發現生物學服務」這一市場定義，並從技術、營運模式、監管、地區、集團和國家等維度梳理了研究結果。分析基於生物醫學研究和實驗室服務交付的既定特徵，包括檢測方法開發、生物建模、數據分析、外包、品管和轉化科學。地區分析著重於特定地區、集團和國家，但不提供市場估算、預測、佔有率、展望或公司具體數據。結論強調可觀察的結構性因素和實施的考量，而非未經證實的量化論點。

結論：整合且管理良好的生物服務能夠促進更好的決策。

隨著科學研究計畫對更豐富的生物學證據、更快的迭代速度以及實驗結果與研發決策之間更緊密的整合提出了更高的要求，發現生物學服務的戰略重要性日益凸顯。該領域的發展受到多種因素的影響，包括技術的融合、人工智慧驅動的分析、區域能力差異以及人們對品質、倫理、安全性和可重複性的日益成長的期望。那些能夠將專業的科學知識與嚴謹的管治、可互通的數據管理以及精心挑選的合作夥伴關係相結合的領導者，將更有能力把複雜的發現信息轉化為值得信賴的決策。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 發現生物服務市場：依服務類型分類

  • 高通量篩檢
    • 生化篩檢
    • 基於細胞的篩檢
    • 高內涵篩檢
  • 體外
    • 類器官
    • 3D細胞培養
    • 2D細胞培養
  • 體內
    • 小鼠模型
    • 大鼠模型
    • 斑馬魚模型
  • 先導藥物最適化
    • Admet 考試
    • 藥物化學
    • 結構設計
  • 體學
    • 基因組學
    • 代謝體學
    • 蛋白質體學
    • 轉錄組學
  • 目標檢驗
    • 功能基因體學
    • 分子譜分析

第8章 發現生物學服務市場：依技術分類

  • CRISPR篩檢
    • 陣列式篩檢
    • 混合篩檢
  • 流式細胞技術
    • 細胞分選
    • 免疫表現型分析
  • 質譜分析
    • 代謝組學分析
    • 蛋白質體學分析
  • 次世代定序
    • RNA定序
    • 全基因測序
  • RNA干擾
    • shRNA篩檢
    • siRNA篩檢

第9章 發現生物學服務市場：依應用領域分類

  • 循環系統
    • 心臟衰竭
    • 高血壓
    • 缺血性疾病
  • 免疫學
    • 過敏
    • 自體免疫疾病
    • 發炎性疾病
  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 病毒感染疾病
  • 神經病學
    • 阿茲海默症
    • 多發性硬化症
    • 帕金森氏症
  • 腫瘤學
    • 骨髓惡性腫瘤
    • 固體癌

第10章 發現生物學服務市場：依最終用戶分類

  • 生物技術
  • 受託研究機構
  • 製藥

第11章 發現生物學服務市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 發現生物學服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 發現生物服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • GenScript Biotech Corporation
  • ICON plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis International AG
  • Pharmaceutical Product Development, LLC
  • PPD, Inc.
  • Sartorius AG
  • Syneos Health
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

第16章 主要專家

Product Code: MRR-9C4233EE5B23

The Discovery Biology Service Market is projected to grow by USD 24.85 billion at a CAGR of 14.58% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.58 billion
Estimated Year [2026] USD 10.78 billion
Forecast Year [2032] USD 24.85 billion
CAGR (%) 14.58%

Discovery Biology Services: Executive Overview

Discovery biology services support early-stage research by applying biological assays, disease models, biomarker analysis, and related laboratory capabilities to questions about target validation, mechanism of action, safety, and therapeutic response. Their role is expanding as research organizations seek specialized expertise, flexible capacity, reproducible data, and faster transitions from hypothesis to candidate evaluation. Demand is shaped by scientific complexity, outsourcing strategies, regulatory expectations, and the need to integrate experimental results across multiple biological systems.

Scientific Complexity Is Reshaping Discovery Biology Delivery

Discovery programs are moving beyond single-assay evidence toward integrated, translational workflows that connect molecular findings with cellular, tissue, and organism-level outcomes. Advances in genomics, proteomics, high-content imaging, organoid systems, single-cell analysis, and functional screening are increasing both the depth of evidence and the requirements for data quality. Service providers and research teams must therefore combine specialized platforms with robust experimental design, standardized protocols, clear chain-of-custody practices, and transparent reporting. Reproducibility, biosafety, ethical governance, and compatibility with downstream development are becoming central selection criteria rather than secondary considerations.

Artificial Intelligence Strengthens Experimental Design and Biological Interpretation

Artificial intelligence is influencing discovery biology through image analysis, pattern recognition, virtual screening, assay optimization, literature synthesis, biomarker discovery, and prediction of experimental outcomes. Its cumulative impact depends on the quality, diversity, and traceability of the underlying data; poorly annotated or nonrepresentative datasets can amplify bias and produce results that are difficult to reproduce. Practical adoption therefore requires human review, validated workflows, model monitoring, secure data infrastructure, and clear controls over intellectual property and patient-derived information. The strongest value emerges when AI augments laboratory expertise and prioritizes experiments rather than replacing empirical validation.

Regional Insights: Capability, Regulation, and Collaboration Shape Adoption

North America benefits from mature biomedical research networks, strong translational infrastructure, and broad access to specialized laboratories, while Latin America is strengthening research capacity through academic collaboration, biopharmaceutical activity, and regionally relevant disease research. Europe combines advanced scientific capabilities with rigorous data protection, animal-welfare, and regulatory frameworks; the Middle East is developing research ecosystems through institutional investment, clinical partnerships, and diversification initiatives. Africa presents significant opportunities linked to infectious disease, genomics, and locally relevant biology, alongside infrastructure and workforce constraints. Asia-Pacific spans highly developed discovery centers and rapidly expanding research capabilities, with collaboration, talent development, quality systems, and cross-border data governance remaining important priorities.

Group Insights: Economic and Security Alliances Influence Research Networks

ASEAN economies are building greater connectivity across academic, clinical, and biotechnology research, although infrastructure and regulatory maturity vary among members. BRICS countries contribute substantial scientific, population, and disease-biology diversity, with collaboration shaped by domestic capability and data-access considerations. The European Union emphasizes coordinated research, harmonized standards, and strong privacy governance, while the G7 supports advanced biomedical innovation through established institutions and funding systems. GCC states are investing in life-science infrastructure, precision medicine, and technology-enabled research. NATO members increasingly recognize the relevance of biological preparedness, secure research practices, and resilient supply chains, while still operating within civilian scientific and ethical frameworks.

Country Insights: Distinct Capabilities Create Complementary Opportunities

Australia combines strong biomedical research with expertise in infectious disease, immunology, and translational science. Brazil and Mexico offer substantial population diversity and important opportunities for disease-relevant research, supported by growing research and clinical ecosystems. Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain benefit from established universities, specialized laboratories, and regulated biomedical networks, with differences in funding structures and compliance requirements. China, India, Japan, and South Korea contribute expanding technological capabilities, advanced instrumentation, and strong scientific talent, while each maintains distinct approval, data, and partnership environments. Russia retains scientific capacity in selected biological fields, although collaboration conditions, access, and international operating constraints require careful assessment.

Action Priorities for Discovery Biology Leaders

Industry leaders should define service specifications around biological questions and decision points rather than individual techniques. They should evaluate partners for assay validation, translational relevance, data integrity, biosafety, regulatory readiness, and the ability to integrate results across platforms. A staged sourcing model can preserve flexibility while protecting continuity for critical programs. Organizations should also establish governance for AI-assisted analysis, including validation datasets, audit trails, human sign-off, and cybersecurity controls. Building regional partnerships, documenting material and data provenance, and investing in interoperable systems can improve resilience and support reliable movement from discovery evidence to development decisions.

Research Methodology: Evidence-Based Executive Synthesis

This executive summary uses the supplied market definition-discovery biology services-as its analytical scope and organizes findings across technology, operating-model, regulatory, regional, group, and country dimensions. Insights are framed from established characteristics of biomedical research and laboratory-service delivery, including assay development, biological modeling, data analysis, outsourcing, quality management, and translational science. Geographic discussion covers the specified regions, groups, and countries without presenting market estimates, shares, forecasts, or company-specific claims. Conclusions emphasize observable structural drivers and implementation considerations rather than unsupported quantitative assertions.

Conclusion: Integrated, Governed Biology Services Enable Better Decisions

Discovery biology services are becoming more strategically important as research programs demand richer biological evidence, faster iteration, and stronger links between experimental findings and development choices. The field is being shaped by technological convergence, AI-enabled analysis, regional capability differences, and heightened expectations for quality, ethics, security, and reproducibility. Leaders that combine specialized scientific expertise with disciplined governance, interoperable data practices, and carefully selected collaborations will be better positioned to convert complex discovery inputs into dependable decisions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Discovery Biology Service Market, by Service Type

  • 7.1. Introduction
  • 7.2. High Throughput Screening
    • 7.2.1. Biochemical Screening
    • 7.2.2. Cell Based Screening
    • 7.2.3. High Content Screening
  • 7.3. In Vitro
    • 7.3.1. Organoids
    • 7.3.2. Three Dimensional Cell Culture
    • 7.3.3. Two Dimensional Cell Culture
  • 7.4. In Vivo
    • 7.4.1. Murine Models
    • 7.4.2. Rat Models
    • 7.4.3. Zebrafish Models
  • 7.5. Lead Optimization
    • 7.5.1. Admet Testing
    • 7.5.2. Medicinal Chemistry
    • 7.5.3. Structure Based Design
  • 7.6. Omics
    • 7.6.1. Genomics
    • 7.6.2. Metabolomics
    • 7.6.3. Proteomics
    • 7.6.4. Transcriptomics
  • 7.7. Target Validation
    • 7.7.1. Functional Genomics
    • 7.7.2. Molecular Profiling

8. Discovery Biology Service Market, by Technology

  • 8.1. Introduction
  • 8.2. CRISPR Screening
    • 8.2.1. Arrayed Screening
    • 8.2.2. Pooled Screening
  • 8.3. Flow Cytometry
    • 8.3.1. Cell Sorting
    • 8.3.2. Immunophenotyping
  • 8.4. Mass Spectrometry
    • 8.4.1. Metabolomic Profiling
    • 8.4.2. Proteomic Profiling
  • 8.5. Next Generation Sequencing
    • 8.5.1. RNA Sequencing
    • 8.5.2. Whole Genome Sequencing
  • 8.6. RNA Interference
    • 8.6.1. ShRNA Screening
    • 8.6.2. SiRNA Screening

9. Discovery Biology Service Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiology
    • 9.2.1. Heart Failure
    • 9.2.2. Hypertension
    • 9.2.3. Ischemic Disease
  • 9.3. Immunology
    • 9.3.1. Allergy
    • 9.3.2. Autoimmune Disorder
    • 9.3.3. Inflammatory Disease
  • 9.4. Infectious Diseases
    • 9.4.1. Bacterial Infection
    • 9.4.2. Fungal Infection
    • 9.4.3. Viral Infection
  • 9.5. Neurology
    • 9.5.1. Alzheimer Disease
    • 9.5.2. Multiple Sclerosis
    • 9.5.3. Parkinson Disease
  • 9.6. Oncology
    • 9.6.1. Hematologic Malignancy
    • 9.6.2. Solid Tumor

10. Discovery Biology Service Market, by End User

  • 10.1. Introduction
  • 10.2. Biotechnology
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceuticals

11. Discovery Biology Service Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Discovery Biology Service Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Discovery Biology Service Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. AstraZeneca PLC
  • 15.2. Bristol-Myers Squibb Company
  • 15.3. Catalent, Inc.
  • 15.4. Charles River Laboratories International, Inc.
  • 15.5. Covance Inc.
  • 15.6. Eurofins Scientific SE
  • 15.7. Evotec SE
  • 15.8. GenScript Biotech Corporation
  • 15.9. ICON plc
  • 15.10. IQVIA Inc.
  • 15.11. Laboratory Corporation of America Holdings
  • 15.12. Lonza Group Ltd.
  • 15.13. Merck KGaA
  • 15.14. Novartis International AG
  • 15.15. Pharmaceutical Product Development, LLC
  • 15.16. PPD, Inc.
  • 15.17. Sartorius AG
  • 15.18. Syneos Health
  • 15.19. Thermo Fisher Scientific Inc.
  • 15.20. WuXi AppTec Co., Ltd.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Discovery Biology Service Market, Years Considered for the Study
  • FIGURE 2. Global Discovery Biology Service Market, Research Design
  • FIGURE 3. Global Discovery Biology Service Market, Research Framework
  • FIGURE 4. Global Discovery Biology Service Market, Data Triangulation
  • FIGURE 5. Global Discovery Biology Service Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Discovery Biology Service Market Size, by Service Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Discovery Biology Service Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Discovery Biology Service Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Discovery Biology Service Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Discovery Biology Service Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Discovery Biology Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Discovery Biology Service Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Discovery Biology Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Discovery Biology Service Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Discovery Biology Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Discovery Biology Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Discovery Biology Service Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Discovery Biology Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Discovery Biology Service Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Discovery Biology Service Market Segmentation & Coverage
  • TABLE 2. Global Discovery Biology Service Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 4. Global High Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global High Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global High Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Biochemical Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Biochemical Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Biochemical Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Cell Based Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Cell Based Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Cell Based Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global High Content Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global High Content Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global High Content Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global In Vitro Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global In Vitro Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global In Vitro Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Organoids Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Organoids Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Organoids Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Three Dimensional Cell Culture Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Three Dimensional Cell Culture Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Three Dimensional Cell Culture Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Two Dimensional Cell Culture Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Two Dimensional Cell Culture Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Two Dimensional Cell Culture Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Murine Models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Murine Models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Murine Models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Rat Models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Rat Models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Rat Models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Zebrafish Models Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Zebrafish Models Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Zebrafish Models Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Admet Testing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Admet Testing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Admet Testing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Medicinal Chemistry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Medicinal Chemistry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Medicinal Chemistry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Structure Based Design Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Structure Based Design Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Structure Based Design Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Omics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Omics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Omics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Genomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 56. Global Genomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 57. Global Genomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 58. Global Metabolomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 59. Global Metabolomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 60. Global Metabolomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 61. Global Proteomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Proteomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Proteomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Transcriptomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Transcriptomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Transcriptomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Target Validation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Target Validation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Target Validation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Functional Genomics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Functional Genomics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Functional Genomics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Molecular Profiling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Molecular Profiling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Molecular Profiling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 77. Global CRISPR Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global CRISPR Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global CRISPR Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Arrayed Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Arrayed Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Arrayed Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Pooled Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Pooled Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Pooled Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Cell Sorting Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Global Cell Sorting Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. Global Cell Sorting Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 92. Global Immunophenotyping Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 93. Global Immunophenotyping Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 94. Global Immunophenotyping Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 95. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 96. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 98. Global Metabolomic Profiling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. Global Metabolomic Profiling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 100. Global Metabolomic Profiling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 101. Global Proteomic Profiling Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Global Proteomic Profiling Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 103. Global Proteomic Profiling Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 104. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 105. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 106. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 107. Global RNA Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 108. Global RNA Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 109. Global RNA Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 110. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 112. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 113. Global RNA Interference Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. Global RNA Interference Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 115. Global RNA Interference Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 116. Global ShRNA Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Global ShRNA Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 118. Global ShRNA Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 119. Global SiRNA Screening Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Global SiRNA Screening Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. Global SiRNA Screening Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 122. Global Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 123. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 124. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 125. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 126. Global Heart Failure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 127. Global Heart Failure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 128. Global Heart Failure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 129. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 130. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 131. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 132. Global Ischemic Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 133. Global Ischemic Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 134. Global Ischemic Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 135. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 136. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 137. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 138. Global Allergy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 139. Global Allergy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 140. Global Allergy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 141. Global Autoimmune Disorder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 142. Global Autoimmune Disorder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. Global Autoimmune Disorder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 144. Global Inflammatory Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Global Inflammatory Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 146. Global Inflammatory Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 147. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 148. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 149. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 150. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 151. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 152. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 153. Global Fungal Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 154. Global Fungal Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 155. Global Fungal Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 156. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 157. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 158. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 160. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 161. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 162. Global Alzheimer Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 163. Global Alzheimer Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 164. Global Alzheimer Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 165. Global Multiple Sclerosis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 166. Global Multiple Sclerosis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 167. Global Multiple Sclerosis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 168. Global Parkinson Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 169. Global Parkinson Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 170. Global Parkinson Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 171. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 172. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 173. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 174. Global Hematologic Malignancy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 175. Global Hematologic Malignancy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 176. Global Hematologic Malignancy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 177. Global Solid Tumor Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 178. Global Solid Tumor Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 179. Global Solid Tumor Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 180. Global Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. Global Biotechnology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 182. Global Biotechnology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 183. Global Biotechnology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 184. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 185. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 186. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 187. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 188. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 189. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 190. Global Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 191. Asia-Pacific Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 192. Asia-Pacific Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 193. Asia-Pacific Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 194. Asia-Pacific Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 195. Asia-Pacific Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 196. Asia-Pacific Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 197. Asia-Pacific Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 198. Asia-Pacific Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 199. Asia-Pacific Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 200. Asia-Pacific Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 201. Asia-Pacific Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 202. Asia-Pacific Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 203. Asia-Pacific Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 204. Asia-Pacific Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 205. Asia-Pacific Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 206. Asia-Pacific Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 207. Asia-Pacific Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 208. Asia-Pacific Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 209. Asia-Pacific Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 210. Asia-Pacific Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 211. Asia-Pacific Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 212. North America Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 213. North America Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 214. North America Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 215. North America Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 216. North America Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 217. North America Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 218. North America Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 219. North America Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 220. North America Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 221. North America Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 222. North America Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 223. North America Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 224. North America Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 225. North America Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 226. North America Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 227. North America Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 228. North America Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 229. North America Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 230. North America Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 231. North America Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 232. North America Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 233. Latin America Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 234. Latin America Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 235. Latin America Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 236. Latin America Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 237. Latin America Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 238. Latin America Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 239. Latin America Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 240. Latin America Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 241. Latin America Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 242. Latin America Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 243. Latin America Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 244. Latin America Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 245. Latin America Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 246. Latin America Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 247. Latin America Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 248. Latin America Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 249. Latin America Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 250. Latin America Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 251. Latin America Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 252. Latin America Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 253. Latin America Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 254. Europe Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 255. Europe Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 256. Europe Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 257. Europe Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 258. Europe Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 259. Europe Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 260. Europe Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 261. Europe Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 262. Europe Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 263. Europe Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 264. Europe Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 265. Europe Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 266. Europe Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 267. Europe Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 268. Europe Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 269. Europe Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 270. Europe Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 271. Europe Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 272. Europe Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 273. Europe Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 274. Europe Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 275. Middle East Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 276. Middle East Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 277. Middle East Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 278. Middle East Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 279. Middle East Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 280. Middle East Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 281. Middle East Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 282. Middle East Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 283. Middle East Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 284. Middle East Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 285. Middle East Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 286. Middle East Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 287. Middle East Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 288. Middle East Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 289. Middle East Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 290. Middle East Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 291. Middle East Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 292. Middle East Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 293. Middle East Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 294. Middle East Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 295. Middle East Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 296. Africa Discovery Biology Service Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 297. Africa Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 298. Africa Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 299. Africa Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 300. Africa Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 301. Africa Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 302. Africa Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 303. Africa Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 304. Africa Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 305. Africa Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 306. Africa Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 307. Africa Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 308. Africa Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 309. Africa Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 310. Africa Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 311. Africa Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 312. Africa Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 313. Africa Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 314. Africa Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 315. Africa Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 316. Africa Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 317. Global Discovery Biology Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 318. ASEAN Discovery Biology Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 319. ASEAN Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 320. ASEAN Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 321. ASEAN Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 322. ASEAN Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 323. ASEAN Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 324. ASEAN Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 325. ASEAN Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 326. ASEAN Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 327. ASEAN Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 328. ASEAN Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 329. ASEAN Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 330. ASEAN Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 331. ASEAN Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 332. ASEAN Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 333. ASEAN Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 334. ASEAN Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 335. ASEAN Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 336. ASEAN Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 337. ASEAN Discovery Biology Service Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 338. ASEAN Discovery Biology Service Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 339. GCC Discovery Biology Service Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 340. GCC Discovery Biology Service Market Size, by Service Type, 2017-2032 (USD Million)
  • TABLE 341. GCC Discovery Biology Service Market Size, by High Throughput Screening, 2017-2032 (USD Million)
  • TABLE 342. GCC Discovery Biology Service Market Size, by In Vitro, 2017-2032 (USD Million)
  • TABLE 343. GCC Discovery Biology Service Market Size, by In Vivo, 2017-2032 (USD Million)
  • TABLE 344. GCC Discovery Biology Service Market Size, by Lead Optimization, 2017-2032 (USD Million)
  • TABLE 345. GCC Discovery Biology Service Market Size, by Omics, 2017-2032 (USD Million)
  • TABLE 346. GCC Discovery Biology Service Market Size, by Target Validation, 2017-2032 (USD Million)
  • TABLE 347. GCC Discovery Biology Service Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 348. GCC Discovery Biology Service Market Size, by CRISPR Screening, 2017-2032 (USD Million)
  • TABLE 349. GCC Discovery Biology Service Market Size, by Flow Cytometry, 2017-2032 (USD Million)
  • TABLE 350. GCC Discovery Biology Service Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
  • TABLE 351. GCC Discovery Biology Service Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
  • TABLE 352. GCC Discovery Biology Service Market Size, by RNA Interference, 2017-2032 (USD Million)
  • TABLE 353. GCC Discovery Biology Service Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 354. GCC Discovery Biology Service Market Size, by Cardiology, 2017-2032 (USD Million)
  • TABLE 355. GCC Discovery Biology Service Market Size, by Immunology, 2017-2032 (USD Million)
  • TABLE 356. GCC Discovery Biology Service Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 357. GCC Discovery Biology Service Market Size, by Neurology, 2017-2032 (USD Million)
  • TABLE 358. GCC Discovery Biology Service Market Size, by Oncology, 2017-203